Summary
The National Cancer Institute (NCI), on behalf of the Center for Cancer Research (CCR), Radiation Oncology Branch (ROB), intends to negotiate and award a sole-source, firm-fixed-price contract to Elekta, Inc. of Atlanta, GA for the acquisition, delivery, installation, commissioning, training, and warranty of an integrated 1.5 Tesla magnetic resonance-guided linear accelerator (MR-Linac) system. The statutory authority cited is 41 U.S.C. § 3304(a)(1) and FAR 6.302-1, based on Elekta being the only source able to meet all minimum technical specifications. Capability statements from any other responsible source that believes it can meet the requirements must be submitted by the response date for the Government's consideration.